GLP-1-ra and heart failure-related outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.

23 May 2023 (09:30 - 10:05)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Assistant Professor Mauro Chiarito

Clinical Institute Humanitas IRCCS, Rozzano (Italy)

3 More presentations in this session

Presentation thumbnail

Left atrial volume index significantly correlates with exercise tolerance of perimenopausal hypertensive women in stage A/B of heart failure.

Doctor K. Janikowski (Lodz, PL)

Abstract Slides

Presentation thumbnail

Prognostic implication of LV dysfunction detected by global longitudinal strain and left ventricular hypertrophy in patients with hypertension

Assistant Professor B. PARK (Daegu, KR)

Abstract Slides

Presentation thumbnail

Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk

Associate Professor A. Phrommintikul (Chiang Mai, TH)

Abstract Slides

Access the full session

Session thumbnail

Heart failure - multi-topics 3

The Event

Event poster

Heart Failure 2023

23 May 2023 09:30 CET

You may be interested in

Congress Presentation

Efficacy and safety of GLP-1 agonists in obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized placebo-controlled trials.

Congress Presentation

Efficacy and safety of semaglutide in patients with obesity-related heart failure: a meta-analysis of randomized clinical trials

Congress Presentation

Effects of glucagon like peptide 1 receptor agonist initiation in patients with heart failure and reduced ejection fraction and implantable cardiac devices

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources